|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-3-7
|
|
pubmed:abstractText |
The presence of numerous mast cells or eosinophils in Hodgkin lymphoma (HL) tumours have both been described as negative prognostic factors. One cytokine related to HL is interleukin-9 (IL-9) and it is known to affect both mast cells and eosinophils. The aim of this study was to explore if the expression of IL-9 correlates to the presence of these inflammatory cells in HL tumours.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0902-4441
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
76
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
278-83
|
|
pubmed:dateRevised |
2007-7-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16519698-Adolescent,
pubmed-meshheading:16519698-Adult,
pubmed-meshheading:16519698-Aged,
pubmed-meshheading:16519698-Aged, 80 and over,
pubmed-meshheading:16519698-Child,
pubmed-meshheading:16519698-Cytoplasm,
pubmed-meshheading:16519698-Eosinophils,
pubmed-meshheading:16519698-Female,
pubmed-meshheading:16519698-Gene Expression Regulation, Leukemic,
pubmed-meshheading:16519698-Hodgkin Disease,
pubmed-meshheading:16519698-Humans,
pubmed-meshheading:16519698-Immunohistochemistry,
pubmed-meshheading:16519698-Inflammation,
pubmed-meshheading:16519698-Interleukin-9,
pubmed-meshheading:16519698-Male,
pubmed-meshheading:16519698-Mast Cells,
pubmed-meshheading:16519698-Middle Aged,
pubmed-meshheading:16519698-Predictive Value of Tests,
pubmed-meshheading:16519698-Prognosis,
pubmed-meshheading:16519698-Receptors, Interleukin,
pubmed-meshheading:16519698-Receptors, Interleukin-9
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
IL-9 expression contributes to the cellular composition in Hodgkin lymphoma.
|
|
pubmed:affiliation |
Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden. ingrid.glimelius@onkologi.uu.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
